SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Diana, Princess of Wales

PatientDiana Spencer
Date of birth1997-07-01
IdentifiersMRN HR-ML028-SYN; SSN (made up) 000-28-5197
Document date2026-03-16
AuthorImogen Castleford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Five-week review: potassium and ECG on fluoxetine 60 mg, CBT-E progress, mood, and safety. [S]

History of Present Illness

Ms. Spencer returns four weeks after the consultation. She has had seven CBT-E sessions, twice a week, and keeps her self-monitoring record every day. Binge eating with vomiting has fallen to about three times a week, and she eats breakfast and lunch on four or five days a week. She took fluoxetine 20 mg for a week, 40 mg for a week, and has taken 60 mg each morning for two weeks. She had mild nausea in the first week, which passed; she sleeps well and has had no agitation or restlessness. The nurse's phone check ten days after the start found no concerns. She has taken potassium chloride twice daily. She has not booked a dental examination. Her mood is better and she has had no thoughts of suicide or self-harm. [S]

ElementDetail
Binge eating and vomitingAbout three times a week, from seven
CBT-ESeven sessions, twice weekly
Fluoxetine60 mg each morning for two weeks; nausea in the first week only
MoodBetter; PHQ-9 9; item 9 scored 0
Dental examinationNot yet booked

Review of Systems

SystemResultFinding
CardiovascularNegativeNo palpitations or fainting
GastrointestinalPositiveVomiting after binges about three times a week; nausea from fluoxetine has passed
Ears, nose, mouth, and throatPositiveTeeth sensitive to cold
PsychiatricNegativeMood better; no agitation; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with foodOne tablet by mouth twice daily with food, swallowed whole with a full glass of waterOral route2026-02-09 to 2026-03-16completedS
Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one weekOne capsule each morning for one week, then two capsules each morning for one weekOral route2026-02-16 to 2026-03-02completedS
Fluoxetine 60 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-03-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-03-16Body height178cmS
2026-03-16Body weight61.6kgS
2026-03-16Body mass index (BMI) [Ratio]19.4kg/m2S
2026-03-16Systolic blood pressure106mm[Hg]S
2026-03-16Diastolic blood pressure66mm[Hg]S
2026-03-16Heart rate70/minS
2026-03-16Respiratory rate14/minS
2026-03-16Body temperature36.6CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-16Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-03-16Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
2026-03-16Chloride [Moles/volume] in Serum or Plasma101mmol/L98-107 mmol/LNormalS
2026-03-16Carbon dioxide, total [Moles/volume] in Serum or Plasma26mmol/L22-29 mmol/LNormalS
2026-03-16Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M106mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-16Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.2 mg/dLNormalS
2026-03-16Q-T interval corrected441msAbove 460 ms is prolonged in womenNormalS
2026-03-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S

Physical Exam

Vital signs recorded on 2026-03-16; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 61.6 kg, BMI 19.4; lying blood pressure 106/66 and pulse 70, standing 104/68 and pulse 82 after three minutes
Head and neckParotid glands a little smaller; enamel erosion unchanged
PsychiatricBrighter; organized; no psychomotor agitation

Problems

ProblemClinical statusVerificationCodeProvenance
Bulimia nervosa, severe: recurrent binge eating, each time with self-induced vomiting, averaging about ten episodes a week for about three years, hidden from everyone; self-worth tied closely to body shape and weight; no laxatives, diuretics, diet pills, or excessive exercise. SCOFF 4 of 5; EDE-Q global score 3.9. Findings: bilateral parotid enlargement, enamel erosion on the inner surfaces of the upper front teeth, calluses on the backs of two knuckles of the right hand, a pulse rise of 22 per minute on standing, low potassium and chloride with a raised bicarbonate, and a raised amylase; BMI 19.3. Synthetic modern episode linked to her own public account of bulimiaactiveconfirmed F50.23S — Synthetic modern diagnosis by DSM-5-TR criteria; severity is graded by the average number of compensatory episodes a week (8 to 13 is severe).
Hypokalemia (potassium 3.1 mmol/L) with low chloride and metabolic alkalosis from repeated vomiting; QTc 452 ms; no palpitations, weakness, or faintingresolvedconfirmed E87.6S — Synthetic presenting laboratory finding; resolved when potassium was normal on two checks.
Major depressive disorder, recurrent, moderate: about two months of low mood, tiredness, poor sleep, and feeling worthless and hopeless, with little pleasure in things she used to enjoy; PHQ-9 14 with item 9 scored 0; an earlier episode of depression after childbirth. Synthetic modern episode linked to her own public account of depressionactiveconfirmed F33.1S — Synthetic modern diagnosis; the earlier episode is the post-natal depression she described publicly.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyBinge-eating and vomiting frequency (her self-monitoring record)Every visitCompleted todayAbout three episodes a week, from seven at the last visit and ten at intake
SurveyEating Disorder Examination Questionnaire (EDE-Q) global scoreBaseline, mid-treatment, and end of treatmentUp to dateGlobal score 3.9 at intake; mid-treatment questionnaire with the therapist at about twelve weeks
ExaminationWeight and BMIEvery visit, and weekly in CBT-E sessionsCompleted today61.6 kg, BMI 19.4; weighed weekly in CBT-E
ExaminationLying and standing pulse and blood pressureEvery visit while purging continuesCompleted todayLying 106/66, pulse 70; standing 104/68, pulse 82 (rise 12)
LaboratoryPotassium, chloride, bicarbonate, and creatinineWeekly until potassium is normal twice, then at each medical visit while purging continuesCompleted todayPotassium 3.9 mmol/L, the second normal value; sodium 140, chloride 101, bicarbonate 26 mmol/L; creatinine 0.78 mg/dL, eGFR 106
LaboratorySecond potassium check one week after the first normal valueWeekly until potassium is normal twiceDeferredNot drawn: the plan at the one-week visit set the next electrolyte check for this visit, four weeks later, instead of one week later. She stayed on potassium chloride throughout, had no symptoms, and potassium today is 3.9 mmol/L, so no harm resulted. Corrective action: while potassium is low or newly normal, electrolytes are drawn weekly at the laboratory between visits
LaboratoryMagnesium and phosphateBaseline, and again while potassium is lowCompleted todayMagnesium 2.0 mg/dL; phosphate normal at intake and not repeated
LaboratoryECG with QTcBaseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been lowCompleted todayQTc 441 ms, from 452 ms, two weeks after reaching fluoxetine 60 mg
ExaminationParotid and dental examination; dental protectionEvery visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continuesDeferredThe dental examination advised at intake has not happened: she put off booking it from embarrassment. Erosion unchanged and no tooth pain, so no harm is evident yet. Corrective action: the clinic gave her a list of dentists who see people with eating disorders, and the therapist will ask about it at the next session
Medication safetyOral potassium supplementWhile potassium is low or vomiting is frequentCompleted todayStopped today after a second normal potassium
Medication safetyFluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts)At the start, one to two weeks after starting or a dose change, then every visitCompleted today60 mg for two weeks; nausea in the first week only; no agitation or suicidal thoughts; the nurse phone check at ten days found no concerns
Self-managementCBT-E attendance and progressUp to 20 sessions over 20 weeks, twice weekly for the first four weeksCompleted todaySeven sessions; self-monitoring record kept daily; weekly from next week
Self-managementRegular eating and dietitian reviewEvery visitCompleted todayBreakfast and lunch on four or five days a week
SurveyDepression measure (PHQ-9)Monthly during acute treatment, then periodicallyCompleted todayPHQ-9 9, item 9 scored 0
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan current; the 988 Suicide & Crisis Lifeline in her phone
ExaminationLevel-of-care review against thresholds for urgent or inpatient careEvery visitCompleted todayOutpatient care remains safe

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: CBT-E weekly. Book a dental examination. Preventive visit in four weeks. Three-month review in eight weeks with electrolytes, the EDE-Q, and the PHQ-9. Next scheduled visit 2026-04-13: periodic adult preventive visit. [S]